Lilly Announces New U.S. Affiliate Leader

Lilly Announces New U.S. Affiliate Leader

INDIANAPOLIS, Sept 22, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Eli Lilly and Company (NYSE: LLY) today announced that David Ricks, currently general manager of Lilly China, has been promoted to president, Lilly USA, LLC. Ricks will succeed Enrique Conterno, who was named leader of Lilly's new Diabetes Business Unit as part of a company reorganization announced Sept. 14.

Ricks said he is honored to be chosen to lead Lilly USA, which is considered Lilly's largest established market.

Ricks, a 13-year Lilly veteran, worked in the U.S. affiliate for several years from 1998 to 2002 as a marketing manager and then as a district sales manager. Most recently, he served as general manager of Lilly Canada from 2005 to 2008, and as general manager of China since July 2008. Ricks received a marketing and finance MBA from Indiana University in 1996. He also holds a bachelor's degree in business management from Purdue University that he received in 1990.

"Under Dave's leadership, Lilly China has embarked upon an ambitious expansion of our sales and marketing organization to compete in this rapidly growing market," said Bryce Carmine, recently named head of the Established Markets Business Unit. "Dave is a proven leader who has delivered strong results in each and every role he has held in the company. He builds strong teams and focuses on individual development; he is well positioned to lead our largest affiliate."

Ricks will report directly to Carmine, and will assume his new role beginning November 1. Eric Baclet, currently vice president of marketing over global neuroscience brands, will succeed Ricks to lead Lilly China.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

Suggested Articles

Last month, rumors out of Bloomberg whispered that Gilead, more known for its COVID-19 work these days, was gearing up for a major stake in Arcus.

The NGOs think Big Pharma controls the agenda of the IMI, leading it to prioritize areas that are profitable for drugmakers over public health needs.

Scientists at McMaster University and the University of Toronto have formed Empirica Therapeutics to bring a CAR-T for glioblastoma into the clinic.